This pharmaceutical company, based in the Middle East, has been operating for several decades. Its primary focus is on research and development, which drives its growth strategy. They provide both prescription and over-the-counter medications, primarily in solid and liquid dosage forms. The company's vertical integration, controlling the entire process from raw material to finished product, gives them an edge in quality, reliability, and cost. Their product portfolio is extensive, including products in key therapeutic areas like cardiology, oncology, and others. Their manufacturing facilities meet international quality standards, holding GMP approvals for both the EU and the USA. The company has a strong global presence, with significant market share in North America and other key regions.
Acetazolamide is a medication used to treat glaucoma, epilepsy, edema, altitude sickness, hydrocephalus, and hypokalemic periodic paralysis. Suppliers of acetazolamide market it in the form of 250mg and 500mg tablets as well as 500mg powders for an injectable solution.
In use for over 50 years, the drug has since become included in the World Health Organization’s List of Essential Medicines that contain the most important drugs recommended for a basic Health System. There are numerous acetazolamide manufacturers and distributors, with the largest globally being companies Teva, TARO, Zydus Pharmaceuticals, and Lannett.
Acetazolamide suppliers and distributors market both generic and trade name formulations of the drug. Buyers are advised that online sellers may attempt to market fraudulent versions of the generic drug, whereas Pipeline Pharma, through its pre-auditing and quality control procedures ensures that only verified acetazolamide manufacturers and wholesalers enter our online marketplace, offering you a risk-free B2B pharmaceutical sales platform.
The retail prices per 20 (250mg) tablets of acetazolamide fall into a range of approximately 4,00 EUR to 5,00 EUR.